Literature DB >> 24903611

Glucose gradients influence zonal matrix deposition in 3D cartilage constructs.

Tim W G M Spitters1, Carlos M D Mota, Samuel C Uzoechi, Barbara Slowinska, Dirk E Martens, Lorenzo Moroni, Marcel Karperien.   

Abstract

Reproducing the native collagen structure and glycosaminoglycan (GAG) distribution in tissue-engineered cartilage constructs is still a challenge. Articular cartilage has a specific nutrient supply and mechanical environment due to its location and function in the body. Efforts to simulate this native environment have been reported through the use of bioreactor systems. However, few of these devices take into account the existence of gradients over cartilage as a consequence of the nutrient supply by diffusion. We hypothesized that culturing chondrocytes in an environment, in which gradients of nutrients can be mimicked, would induce zonal differentiation. Indeed, we show that glucose gradients facilitating a concentration distribution as low as physiological glucose levels enhanced a zonal chondrogenic capacity similar to the one found in native cartilage. Furthermore, we found that the glucose consumption rates of cultured chondrocytes were higher under physiological glucose concentrations and that GAG production rates were highest in 5 mM glucose. From these findings, we concluded that this condition is better suited for matrix deposition compared to 20 mM glucose standard used in a chondrocyte culture system. Reconsidering the culture conditions in cartilage tissue engineering strategies can lead to cartilaginous constructs that have better mechanical and structural properties, thus holding the potential of further enhancing integration with the host tissue.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24903611      PMCID: PMC4259192          DOI: 10.1089/ten.TEA.2014.0059

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  40 in total

1.  Gas exchange is essential for bioreactor cultivation of tissue engineered cartilage.

Authors:  B Obradovic; R L Carrier; G Vunjak-Novakovic; L E Freed
Journal:  Biotechnol Bioeng       Date:  1999-04-20       Impact factor: 4.530

2.  Cartilage intermediate layer protein 2 (CILP-2) is expressed in articular and meniscal cartilage and down-regulated in experimental osteoarthritis.

Authors:  Bianca C Bernardo; Daniele Belluoccio; Lynn Rowley; Christopher B Little; Uwe Hansen; John F Bateman
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

3.  In vivo screening of extracellular matrix components produced under multiple experimental conditions implanted in one animal.

Authors:  Gustavo A Higuera; Jeanine A A Hendriks; Joost van Dalum; Ling Wu; Roka Schotel; Liliana Moreira-Teixeira; Mirella van den Doel; Jeroen C H Leijten; Jens Riesle; Marcel Karperien; Clemens A van Blitterswijk; Lorenzo Moroni
Journal:  Integr Biol (Camb)       Date:  2013-06       Impact factor: 2.192

4.  Polymer scaffolds fabricated with pore-size gradients as a model for studying the zonal organization within tissue-engineered cartilage constructs.

Authors:  T B F Woodfield; C A Van Blitterswijk; J De Wijn; T J Sims; A P Hollander; J Riesle
Journal:  Tissue Eng       Date:  2005 Sep-Oct

5.  Expression and function of the insulin receptor in normal and osteoarthritic human chondrocytes: modulation of anabolic gene expression, glucose transport and GLUT-1 content by insulin.

Authors:  S C Rosa; A T Rufino; F Judas; C Tenreiro; M C Lopes; A F Mendes
Journal:  Osteoarthritis Cartilage       Date:  2011-02-13       Impact factor: 6.576

6.  Integrin α1β1 participates in chondrocyte transduction of osmotic stress.

Authors:  Christina L Jablonski; Samuel Ferguson; Ambra Pozzi; Andrea L Clark
Journal:  Biochem Biophys Res Commun       Date:  2014-02-02       Impact factor: 3.575

7.  High-concentration of BMP2 reduces cell proliferation and increases apoptosis via DKK1 and SOST in human primary periosteal cells.

Authors:  Harry K W Kim; Ila Oxendine; Nobuhiro Kamiya
Journal:  Bone       Date:  2013-01-27       Impact factor: 4.398

8.  Increased osmolarity and cell clustering preserve canine notochordal cell phenotype in culture.

Authors:  Sandra Spillekom; Lucas A Smolders; Guy C M Grinwis; Irene T M Arkesteijn; Keita Ito; Björn P Meij; Marianna A Tryfonidou
Journal:  Tissue Eng Part C Methods       Date:  2014-02-14       Impact factor: 3.056

Review 9.  Synthesis and sorting of proteoglycans.

Authors:  K Prydz; K T Dalen
Journal:  J Cell Sci       Date:  2000-01       Impact factor: 5.285

10.  Hypoxia promotes redifferentiation and suppresses markers of hypertrophy and degeneration in both healthy and osteoarthritic chondrocytes.

Authors:  Brandon D Markway; Holly Cho; Brian Johnstone
Journal:  Arthritis Res Ther       Date:  2013-08-21       Impact factor: 5.156

View more
  4 in total

1.  A developmentally inspired combined mechanical and biochemical signaling approach on zonal lineage commitment of mesenchymal stem cells in articular cartilage regeneration.

Authors:  Tahereh Karimi; Danial Barati; Ozan Karaman; Seyedsina Moeinzadeh; Esmaiel Jabbari
Journal:  Integr Biol (Camb)       Date:  2015-01       Impact factor: 2.192

2.  Mimicking Cartilage Tissue Zonal Organization by Engineering Tissue-Scale Gradient Hydrogels as 3D Cell Niche.

Authors:  Danqing Zhu; Xinming Tong; Pavin Trinh; Fan Yang
Journal:  Tissue Eng Part A       Date:  2017-08-22       Impact factor: 3.845

3.  Nondestructive assessment of tissue engineered cartilage based on biochemical markers in cell culture media: application of attenuated total reflection Fourier transform infrared (ATR-FTIR) spectroscopy.

Authors:  William Querido; Sabrina Zouaghi; Mugdha Padalkar; Justin Morman; Jessica Falcon; Shital Kandel; Nancy Pleshko
Journal:  Analyst       Date:  2022-04-11       Impact factor: 5.227

4.  Microfluidic nutrient gradient-based three-dimensional chondrocyte culture-on-a-chip as an in vitro equine arthritis model.

Authors:  J Rosser; B Bachmann; C Jordan; I Ribitsch; E Haltmayer; S Gueltekin; S Junttila; B Galik; A Gyenesei; B Haddadi; M Harasek; M Egerbacher; P Ertl; F Jenner
Journal:  Mater Today Bio       Date:  2019-08-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.